Skip to content

Home
Insights
Brochures
Careers
About us
News

Home
Insights
Brochures
Careers
About us
News

Pharma News

Highlights from the Week of 21st September 2026 - 28th September 2026 ( FDA, Approval ) Mirum obtains FDA approval for ATEBRIOZ tablets to reduce the volume of HO in those aged 12 years and older with FOP ( FDA, Approval ) Lantheus gets final approval from FDA for BRAVNETSA to treat adults with somatostatin receptor-positive GEP-NETs, including foregut, midgut, and hindgut neuroendocrine tumors ( FDA, Approval ) Eli Lilly gains FDA approval for ONSWIK, indicated along with diet and exercise, to control high blood sugar in adults with type 2 diabetes ( FDA, Approval ) FDA grants approval to Elevar Therapeutics' LYRFIGTU as a treatment option for CCA with FGFR2 fusion or other rearrangement Pg 1/5 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 21st Sep – 28th Sep in the world of pharma and healthcare!

September 28, 2026

Highlights from the week of 14th Sep - 21st Sep Alfasigma ( CHMP, Positive Opinion ) CHMP issues positive opinion for Alfasigma's filgotinib to treat axSpA in patients with an inadequate response to conventional therapy Novo Nordisk ( CHMP, Positive Opinion ) Novo Nordisk gets positive CHMP opinion for SOGROYA, administered once weekly, for children with ISS and persistent growth disturbances AstraZeneca ( CHMP, Positive Opinion ) CHMP recommends positive opinion to AstraZeneca's ENHERTU as a monotherapy for the adjuvant treatment of adults with resected HER2-positive breast cancer Roche ( CHMP, Positive Opinion ) Roche gains a positive CHMP opinion for its OCREVUS IV infusion to treat patients aged 10 years and older with RMS All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 14th Sep – 21st Sep in the world of pharma and healthcare!

September 21, 2026

Highlights from the Week of 07th September 2026 - 14th September 2026 ( FDA, Accelerated Approval ) FDA provides accelerated approval to Bayer's sevabertinib to treat locally advanced or metastatic NSCLC with HER2/ERBB2 tumors ( FDA, Priority Review ) FDA accepts Takeda's TAK-279 under Priority Review to treat adults with moderate-to-severe plaque psoriasis ( FDA, Priority Review ) Genentech receives Priority Review from FDA for its sBLA, ENSPRYNG to treat MOGAD ( FDA, Fast Track ) Sobi obtains Fast Track designation from FDA for pacritinib to treat VEXAS syndrome Pg 1/3 All logos and trademarks remain the intellectual properties of their respective owners

Highlights from the Week of 07th September – 14th September in the world of pharma and healthcare!

September 14, 2026

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Investor calendar

2026 RBC Capital Markets Global Healthcare Conference Bank of America Global Healthcare Conference Sep 22,2026 To Sep 23,2026 Sep 23 Sep 22 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of Sep 22,2026 To Sep 23,2026

September 21, 2026

2026 RBC Capital Markets Global Healthcare Conference Morgan Stanley 24th Annual Global Healthcare Conference Sep 14,2026 To Sep 15,2026 Sep 15 Sep 14 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of September 14,2026 To September 15,2026

September 14, 2026

2026 RBC Capital Markets Global Healthcare Conference Wells Fargo 21st Annual Healthcare Conference Sep 09,2026 To Sep 10,2026 Sep 10 Sep 09 All logos and trademarks remain the intellectual properties of their respective owners

Attention stay up to date with the latest investor calls by checking out our calendar for the week of September 09,2026 To September 10,2026

September 7, 2026

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Healthcare Insights

On World Lupus Day, we stand in support of everyone affected by lupus — raising awareness, encouraging early diagnosis, and advocating for better care and research. 💜Together, we can help improve lives through awareness, innovation, and compassion.

May 10, 2026

WORLD THALASSEMIA DAY HIDDEN NO MORE - Finding the Undiagnosed, Supporting the Unseen AN INHERITED HEMOGLOBIN DISORDER Thalassemia is a genetic condition caused by mutations in globin genes that lead to an imbalance of α- and β-globin chains, resulting in red blood cell destruction The 2026 Global Mission: To identify undiagnosed individuals and support those whose daily challenges remain unrecognized by society & healthcare systems Global Lighting Initiative "Bring To Light" movement encourages cities to illuminate iconic landmarks in red to symbolize solidarity and advocacy Alpha vs. Beta Thalassemia PREVALENCE Alpha Beta Alpha types involves deletions on chromosome 16 Beta types usually involve point mutations on chromosome 11 Minor vs. Major (TDT vs. NTDT) 1.3 M Global Cases Among them, 400,000 children are born with severe forms annually Mild Severe Minor/Trait Major/Transfusion-Dependent Often asymptomatic carriers Requires lifelong blood support for survival THALASSEMIA BELT REGIONS SYMPTOMS & COMPLICATIONS Chronic fatigue Pale skin Jaundice Shortness of breath Bone deformities Growth retardation THE TREATMENT REVOLUTION CASGEVY REBLOZYL Cell-based gene therapy Erythroid maturation agent The Danger of Iron Overload STANDARD CARE: TRANSFUSIONS & CHELATION Frequent transfusions can lead to iron accumulation, causing and organ damage Regular blood transfusions to maintain hemoglobin levels and iron chelation therapy to remove excess iron from the body Vyuhpharma® All Rights Reserved Note: This report is generated based on publicly available data

Every drop of awareness brings hope ❤️On World Thalassemia Day, we work together to create awareness on thalassemia, encourage early diagnosis and better access to care, and support patients and their families Together, we can help build a healthier and stronger future for every life affected by thalassemia

May 8, 2026

WORLD ASTHMA DAY MAY 5, 2026 BREATHE EASY , LIVE FULLY What Is Asthma? It is a chronic, non-communicable, inflammatory condition.That causes the airways in the lungs to swell, narrow, and produce extra mucus. ASTHMA CAN AFFECT ANYONE, AT ANY AGE 363M to 434M High Total Globally Approximately Prevalent in Children & Adolescents, Particularly Aged 5–9 and 10–17 Years, respectively 442L to 450L Total Mortality Low Adolescents Children 5–9 Yrs 10–17 Yrs Key Insight: Over 90% of deaths occur in low-to-middle income countries due to a lack of access to inhaled corticosteroids Low prevalence High prevalence Moderate prevalence Types of Asthma Allergic Asthma Non-Allergic Asthma Occupational Asthma Exercise-Induced Bronchoconstriction Cough-Variant Asthma Aspirin-Induced Asthma Common Tiggers Asthma Symptoms Air pollution Allergens Tobacco smoke Infection Physical activity Emotional stress Wheezing Shortness of Breath Chest Tightness Persistent Cough Key Management Strategy Microscopic View Healthy Airway Severe Asthma Airway smooth muscle: Hyperresponsiveness Constriction Thickening Early diagnosis and regular monitoring Adherence to prescribed medications Avoidance of known triggers Patient education awareness Asthma action plan Subepithelial inflammation and fibrosis Mucus hypersecretion and impaired mucus clearance Treatment Regimen Main Role Top Examples Medication Increased eosinophils and/or neutrophils in airway lumen Daily Controller (ICS) Prevents swelling/mucus Pulmicort, Arnuity, QVAR Combination (ICS+LABA) Long-term control + open airways Symbicort, Breo, Dulera AIR / MART Therapy One inhaler for daily use Symbicort (Budesonide/Formoterol) Quick Reliever (SABA) Immediate "emergency" relief Albuterol (Ventolin, ProAir) Add-on (LAMA/LTRA) Extra support for difficult symptoms Spiriva, Singulair Biologics Targeted injections for severe cases Dupixent, Tezspire, Exdensur Oral Steroids (OCS) Short-term "reset" for major flares Prednisone Bronchial Comparison Air trapped in alveoli Relaxed smooth muscles Tightened smooth muscles Wall inflamed and thickened Asthmatic airway during attack Normal airway Asthmatic airway

On World Asthma Day 2026, we stand for every breath, every life that matters.Asthma affects millions worldwide; yet, with the right awareness, early diagnosis and consistent care, it can be managed effectively.Let’s work together to create environments that support healthier lungs and better lives.

May 5, 2026

« Previous Page1 Page2 Page3 Page4 Page5 Next »

The Pharma BI division of

Vyuhgenics Inc.

Henderson, Nevada, USA – 89014

Vyuhpharma ®, All Rights Reserved.

Sitemap

Terms of Use

Privacy Policy

Connect with us

Please fill in the information below, and we'll get back to you.

Full Name

Email Address

Your Company

Contact

Your message